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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A194BtgI did not show any signiﬁcant (p>0.05) association with these clin-
ical features nor with WOMAC pain. The association of CALM-1 gene
with radiological severity was signiﬁcant in all the three SNPs studied;
CALM-1 ApaLI (F¼ 9.36, p<0.001), CALM-1 ApeKI (p<0.001) and CALM-
1 rs2300496 (F¼ 3.96, p<0.001). Further, the Tukey test showed sig-
niﬁcantly (p<0.001) different and higher mean radiological severity in
CT and TT genotypes of CALM-1 ApaLI as compared to CC genotype; in
CALM-1 rs2300496 the mean radiological severity in CC genotype was
signiﬁcantly (p<0.05) different and higher as compared to AA genotype
and in CALM-1 ApeKI, the mean radiological severity in TG genotype
was signiﬁcantly (p<0.001) different and higher as compared to TT
genotype. However GDF-5* rs 331383 and ESR-a BtgI rs* 2228480 did
not show any signiﬁcant association with mean radiological severity.
Conclusions: In this study we found that in cases of knee osteoarthritis,
GDF-5* rs 331383 and CALM-1 ApekI genotype had signiﬁcant associ-
ation with WOMAC pain; all the three SNPs of CALM-1 genotype had
signiﬁcant association with radiological severity and ESR-a BtgI geno-
type did not show any association with either clinical or radiological
features. These ﬁnding validate our contention that genetic variants
inﬂuence knee pain and radiological changes in knee osteoarthritis and
different genotypes being responsible for the severity in these two
parameters may be responsible for the clinical and radiological dis-
cordance being reported by several authors.
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DIFFERENTIAL DNA METHYLATION AND EXPRESSION OF
INFLAMMATORY AND ZINC TRANSPORTER GENES DEFINES SUB-
GROUPS OF OSTEOARTHRITIC HIP PATIENTS
M.D. Rushton, D.A. Young, J. Loughlin, L.N. Reynard. Newcastle Univ.,
Newcastle upon Tyne, United Kingdom
Purpose: Using the Inﬁnium HumanMethylation450 BeadChip (Illu-
mina), which measures the level of DNA methylation at approximately
480,000 CpG sites throughout the human genome, we have previously
shown that the cartilage DNA methylome delineates two groups, or
clusters, of osteoarthritic (OA) hip patients. These two clusters, which
we designated clusters 1 and 2, are characterized by differential
methylation of genes involved in inﬂammation. In that study we had
also analyzed a group of age-matched patients who were free of hip OA
but who had undergone hip replacement due to a neck of femur (NOF)
fracture. OA hip cluster 1 was more similar at the methylation level to
the NOF patients than was OA hip cluster 2. In this study we aimed to
investigate the two OA hip clusters in more detail to ascertain what are
the key methylation and gene expression features that distinguish
them.
Methods: Using our HumanMethylation450 BeadChip data we
searched for CpG sites that were signiﬁcantly differentially methylated
between OA hip cluster 2 and both OA hip cluster 1 and the NOF
patients (Kruskal-Wallis test, p<0.05, 10% or greater difference in
methylation). Gene ontology (GO) term analysis was used to identify
pathways hypo or hyper methylated. Gene expressionwas measured by
real time quantitative RT-PCR and relative to the housekeeping gene 18s
rRNA.
Results: We identiﬁed 10071 differentially methylated loci (DMLs), of
which 4313 were hypomethylated and 5758 were hypermethylated in
OA hip cluster 2 compared to both NOF and OA hip cluster 1. GO term
analysis revealed a striking enrichment of terms related to inﬂamma-
tion and immunity. Cluster 2 was characterized by the promoter
hypomethylation and increased expression of inﬂammation-associated
genes including TNF, IL6, CXCR2, CCL5, IL1A and CCL2 (all p-values
<0.01). Expression of these genes inversely correlated with methylation
levels at the differentially methylated CpG sites. Recently it has been
shown that elevated intracellular zinc levels are involved in the up
regulation of metalloproteinases in OA and that inﬂammatory factors
such as IL1 and IL6 regulate the ZIP group of zinc transporters. We found
that the increase in expression of the inﬂammation-associated genes in
hip cluster 2 was accompanied by an increase in the expression of
several of the zinc transporter genes including ZIP3, ZIP4, ZIP7, ZIP8,
ZIP11 and ZIP14 (all p-values <0.05). Furthermore, ZIP4, ZIP7, ZIP11 and
ZIP14 were differentially methylated between our two OA hip clusters
(all p-values <0.05). In addition the zinc responsive transcription factor
MTF1 was also up-regulated in cluster 2 (p<0.001), which was
accompanied by an increase in the expression of its downstream targets
the metalloproteinase genes MMP13 and ADAMTS5 (both p-values
<0.001).Conclusions: We have identiﬁed a sub-group of OA hip patients that is
epigenetically and transcriptionally characterized by a cartilage
inﬂammatory phenotype with concurrent differential expression of
zinc regulators. The emerging role of zinc in the induction of matrix-
degrading enzyme expression in chondrocytes has led to the suggestion
that zinc regulation could offer therapeutic opportunities in OA. Our
data supports this suggestion but very clearly highlights that this may
be particularly applicable to a sub-group of OA individuals. The iden-
tiﬁcation of sub-groups therefore enhances stratiﬁed phenotyping of
OA patients and has important implications for future therapeutic
applications. For example, the administration of anti-inﬂammatories
may be more efﬁcacious for patients who fall into cluster 2 than those
who fall into cluster 1.
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GENOME-WIDE DNA METHYLATION STUDY OF HIP AND KNEE
CARTILAGE REVEALS EMBRYONIC ORGAN AND SKELETAL SYSTEM
MORPHOGENESIS AS MAJOR PATHWAYS INVOLVED IN
OSTEOARTHRITIS
E. Aref-Eshghi, Y. Zhang, M. Liu, P.E. Harper, G. Martin, A. Furey,
R. Green, P. Rahman, G. Zhai. Mem. Univ. of Newfoundland, St John's, NL,
Canada
Purpose: The objectives of this study were to describe the genomewide
DNA methylation changes in hip and knee osteoarthritis (OA) and to
identify novel genes and pathways involved in OA by comparing the
DNA methylome of the hip and knee osteoarthritic cartilage with those
of healthy individuals.
Methods: OA cartilage samples were collected from the tibial plateau
and femoral head articular surfaces of patients with severe OA under-
going total hip/knee replacement surgery. Healthy cartilage samples
were obtained from individuals with femoral neck fractures, but no OA.
Chondrocyte DNA methylation was assayed by Illumina Inﬁnium
HumanMethylation450 BeadChip array, allowing for the analysis of
>480,000 CpG sites. A sub-analysis was also done to compare hip and
knee OA. An independent sample T-test was conducted for each CpG
site and those sites with at least 10% methylation difference and a P-
value of <0.0001 were selected as differentially methylated regions
(DMR). DAVID v6.7 was used for the functional annotation clustering of
the DMR genes.
Results: The study population comprises 5 patients with hip OA, 6
patients with knee OA and 7 hip samples from healthy individuals. The
comparisons of hip, knee and combined hip/knee OA patients with
controls resulted in 26, 72, and 103 DMRs, respectively. The comparison
between hip and knee OA revealed 67 DMRs. The overall number of the
sites after considering the overlaps was 239, among which 151 sites
were annotated to 145 genes. 28 of these genes were reported in pre-
vious methylation studies of OA. The functional annotation clustering of
the identiﬁed genes revealed clusters signiﬁcantly enriched in skeletal
system morphogenesis (bonferroni corrected p¼8.4e-9) and develop-
ment (bonferroni corrected p¼9.0e-6), embryonic organ (bonferroni
corrected p¼1.4e-5) and skeletal system morphogenesis (bonferroni
corrected p¼9.9e-7), as well as Homeobox genes (bonferroni corrected
p¼3.1e-4). A sub-analysis after the removal of the genes differentially
methylated between hip and knee OA highlighted the same pathways
excluding Homeobox genes.
Conclusions:We demonstrated a number of CpG sites and genes across
the genome differentially methylated among OA patients and controls,
a remarkable portion of which seem to be involved in potential etiologic
mechanisms of OA. Genes involved in skeletal developmental pathways
and embryonic organ morphogenesis may be a potential area of con-
centration for future osteoarthritis genetic/epigenetic research.
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GENOME-WIDE DNA METHYLATION PROFILING OF OSTEOARTHRITIC
ARTICULAR CARTILAGE
Y. Zhang y, N. Fukui z, M. Yahata y, M. Lee y. yRIKEN, Yokohama, Japan;
zUniv. of Tokyo, Tokyo, Japan
Purpose: The aim of this study was to characterize the genome-wide
DNA methylation proﬁle of cartilage from knee joints obtained from
patients with primary osteoarthritis (OA) who underwent arthroplasty,
and providing the ﬁrst comparison of DNA methylation among the
cartilage representing early (outer lateral tibial plateaus, oLT),
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A195intermediate (inner lateral tibial plateaus, iLT) and late stage (inner
medial plateaus, iMT) of OA in Japanese.
Methods: Genome-wide DNA methylation analysis was performed
using Illumina Inﬁnium HumanMethylation450 BeadChip array on DNA
extracted from the cartilage of oLT, iLT and iMT region of 8 patients. Raw
IDAT ﬁles were analyzed using package “minﬁ” in R. Data was nor-
malized through SWAN (subquantile normalization) method. Multi-
dimensional scaling (MDS) was used to identify the outliers. Probes that
locate on X/Y chromosomes were removed before applying F test to ﬁnd
out the differential methylated sites of iLT vs oLT and iMT vs oLT. Mul-
tidimensional scaling of the methylation beta values revealed sig-
niﬁcantclusters related to cartilage. F test with p value less than 0.05
and jDbj greater than 0.15 were used to identify the differential
methylated sites. Genes with differentially methylated CpG sites were
analyzed to identify gene ontologies, pathways, and upstream
regulators.
Results: We identiﬁed 310 differentially methylated sites (DMS) cov-
ering 147 genes in comparison of iMT vs. oLT region. Of these, 122(39%)
DMS were hypermethylated and 188 (61%) were hypomethylated.
However, in the comparison of iLT vs. oLT region, we only found 22
differential methylated sites (12 hypermethylated and 10 hypomethy-
lated). The dramatic difference in DMS numbers of iLT and iMT suggests
that methylation is highly involved only at the very late stage of OA. The
DMS we found in iMT cartilage include genes reported related to OA, for
instance, BMP6, COL14A1, NFATC1, and SPOCK1. Enrichment analysis of
the genes with DMS revealed signiﬁcant enrichment of HOX family
genes and development pathways.
Conclusions: In the current study, we have identiﬁed the methylation
changes in both the iLT region and iMT region, which represent the
intermediat and late stage of OA disease. Our data suggested that the
signiﬁcant changes in methylation occurred at during the late stages of
OA. The development pathways and HOX family genes enriched at the
late stage of OA implicated new aspect of cartilage maintenance in
adulthood. The further study of the underlying mechanism may supply
a direction for future cartilage regeneration approaches.
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GENOME-WIDE DNA METHYLATION PROFILING OF OSTEOARTHRITIC
SUBCHONDRAL BONE
Y. Zhang y, N. Fukui z, M. Yahata y, M. Lee y. yRIKEN, Yokohama, Japan;
zUniv. of Tokyo, Tokyo, Japan
Purpose: Osteoarthritis (OA) is a disease of the whole joint organ
involving pathological changes of articular cartilage (AC) and structural
changes of underlying subchondral bone (SB). Several studies looking at
changes in methylation has been performed, but none of them were
performed on the subchondral bone. We previously reported a novel
method for isolating site-matched overlying AC and underlying SB from
regions of interest respectively from the human knee tibial plateau.
Thus, the aim of this study was to characterize the genome-wide DNA
methylation proﬁle from regions representing early (oLT), intermediate
(iLT) and late stage (iMT) of OA in the subchondral bone from knee
joints isolated from arthroplasty in the Japanese population.
Methods: Genome-wide DNA methylation proﬁling was performed
using the Illumina Inﬁnium HumanMethylation450 BeadChip array in
the DNA extracted from the subchondral bone of 8 patients. Raw IDAT
ﬁles were analyzed using the package “minﬁ” in R. Normalization of the
data was performed through the SWAN (subquantile normalization)
method. The outliers were identiﬁed using multidimensional scaling
(MDS). Probes on X/Y chromosomes were removed. F test was used to
determine the differential methylated sites between iLT vs oLT and iMT
vs oLT. Multidimensional scaling of the methylation beta values reveals
signiﬁcant clusters related to subchondral bone. F test with p smaller
than 0.05 and the cutoff threshold of jDbj greater than0.15 were used to
identify the differential methylated sites. Genes with differentially
methylated CpG sites were analyzed to identify gene ontologies, path-
ways, and upstream regulators.
Results: A total of 252 differentially methylated sites (DMS) covering
119 genes in comparison of iMT vs. oLT region. Of these, 114(45%) DMS
were hypermethylated and 138 (55%) were hypomethylated. However,
in the comparison of iLT vs. oLT region, we only found 35 differential
methylated sites (23 hypermethylated and 12 hypomethylated). The
dramatic difference in DMS numbers of iLT and iMT suggests that
methylation is highly involved at the late stage of OA. Enrichmentanalysis of the genes with DMS of iMT vs oLT revealed signiﬁcant
enrichment of HOX family genes, skeletal development and morpho-
genesis pathways, and transcription regulatory pathways, which is
similar to the result from cartilage, but the members of HOX family
genes differ, HOXC genes showed changed methylation status only in
subchondral bone but not cartilage. Genes with DMS of iLT vs oLT
showed enrichment of DNA binding and transcription regulation, but
not HOX or development.
Conclusions: To our best knowledge, this study represents the ﬁrst and
the most comprehensive direct assessment of methylation proﬁling
conducted in OA subchondral bone. With the ability to directly studying
genetic proﬁles of subchondral bone could further the understanding of
the pathogenesis of the disease.
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TRANSTHYRETIN AND AMYLOID IN CARTILAGE AGING AND
OSTEOARTHRITIS
Y. Akasaki y, O. Alvarez-Garcia y, N. Reixach y, J.N. Buxbaum y,
Y. Iwamoto z, M.K. Lotz y. y The Scripps Res. Inst., La Jolla, CA, USA;
zKyushu Univ., Fukuoka, Japan
Purpose: Deposition of amyloid is a common aging-associated phe-
nomenon and a key factor in the pathogenesis of several aging-related
diseases. Osteoarthritis (OA) is the most prevalent joint disease and
aging is its major risk factor. Although amyloid deposits appear to be a
prevalent in OA-affected joints, their composition and effects on cell
and tissue function are unknown. Transthyretin (TTR) is an amyloido-
genic protein. Point mutations in the TTR gene cause of familial amy-
loidotic polyneuropathy and cardiomyopathy. Wild-type TTR can also
assemble into amyloid deposits and this may be facilitated by oxidation,
or the presence of sulfated glycosaminoglycans. This study addressed
TTR deposition in aging and OA-affected knee cartilage and effects of
TTR on chondrocyte function.
Methods: Amyloid deposition in normal and OA human knee cartilage
was determined by Congo-red staining and polarized light microscopy.
TTR in cartilage and synovial ﬂuid was analyzed by immunohis-
tochemistry and western blotting. TTR gene expression in chondrocytes
was studied by quantitative PCR and RNA sequencing. Effects of wild
type and mutant TTR were studied in normal human chondrocyte
cultures with measurements of cell viability and OA-related gene
expression.
Results: There was no amyloid deposition in young normal cartilage. In
contrast, 58% (7/12) of aged normal cartilage and 100% (12/12) of OA
cartilage samples had Congo red staining. TTR was detectable in all OA
and a majority of aged but not in young normal cartilage and pre-
dominantly located at the cartilage surfaces. TTR is not produced by
chondrocytes at substantial levels and synovial ﬂuid levels are similar in
normal and OA affected knees. In chondrocytes, TTR induces cell death,
the expression of proinﬂammatory cytokines and extracellular matrix
degrading enzymes. This was observed for the amyloidogenic but not
for the non-amyloidogenic TTR mutant. Effects of TTR on cell viability
and gene expression are mediated by activation of TLR4 signaling and
MAP kinases. TTR-induced cytotoxicity was inhibited by resveratrol, a
plant polyphenol and the salicylic acid derivate diﬂunisal which both
stabilize the native tetrameric structure of TTR. Studies using transgenic
mice that overexpress wild type human TTR showed that surgically
induced OA was more severe than in wild type mice. In addition, hTTR
transgenic mice also showed more severe spontaneous aging related
OA-like joint changes in cartilage and synovium.
Conclusions: These ﬁndings are the ﬁrst to suggest that TTR amyloid
deposition may not represent an inconsequential aging-related phe-
nomenon but contribute to cell and extracellular matrix damage in
articular cartilage.
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DEVELOPMENTAL SWITCH IN SOX9 EXPRESSION IN ARTICULAR
CARTILAGE IS REGULATED BY EPIGENETIC HISTONE METHYLATION
M. ZHANG, Q. Hua, A. Miller, N. Barnthouse, J. Wang. Univ. of Kansas
Med. Ctr., Kansas City, KS, USA
Purpose:While the role of the SOX9 transcription factor in chondrocyte
differentiation and cartilage formation during skeletal development is
well documented, age-dependent SOX9 expression in articular
